✦ LIBER ✦

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats

✍ Scribed by Antonia Serrano; Ignacio del Arco; Francisco Javier Pavón; Manuel Macías; Vidal Perez-Valero; Fernando Rodríguez de Fonseca

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment with SR141716A, the

✍ Tiziana Rubino; Paola Massi; Daniela Viganò; Domenica Fuzio; Daniela Parolaro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Contextual renewal of nicotine seeking i

✍ L. Diergaarde; W. de Vries; H. Raasø; A.N.M. Schoffelmeer; T.J. De Vries 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 211 KB

The cannabinoid CB1 receptor antagonist,

✍ Victoria Chapman 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Effect of the cannabinoid CB1receptor an

✍ Daina Economidou; Laura Mattioli; Carlo Cifani; Marina Perfumi; Maurizio Massi; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 189 KB

Arousal-enhancing properties of the CB1

✍ Vincent Santucci; Jean-jacques Storme; Philippe Soubrié; Gérard Le Fur 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 569 KB

The cannabinoid CB1 receptor antagonist

✍ Salvatora Succu; Maria Stefania Mascia; Fabrizio Sanna; Tiziana Melis; Antonio A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 490 KB